Make a Mess, Then Scale: A Life Science Founder Playbook
David Nathan says "make a mess, then clean it up" beats waiting to scale. SPI 2025 and CB Insights data show why that path works for services firms.
Why Firing the Team Won’t Fix Biotech Culture: Froggatt
Most biotechs respond to culture rot with layoffs. The Stephenson primate research and Edmondson’s psychological safety data show why that almost never works.
Solo Founder Math: 82% Fail. What Survives in Life Science
The data on bootstrap odds, solo vs co-founder success rates, and what Guillaume’s $10K Biotech Connect bet reveals about going alone in life science.
Patient Access After FDA Approval: Kaitlyn Sai’s $8K Story
FDA approval doesn’t equal patient access. The IQVIA, FDA, and crowdfunding data behind the specialty drug coverage gap, and what life science teams can do.